C4A and C4B null alleles are genetic markers of different types of systemic sclerosis in Japanese patients. 1998

F Takeuchi, and H Nabeta, and G H Hong, and K Matsuta, and K Tokunaga, and K Tanimoto, and K Nakano
Dept. of Medicine and Physical Therapy, Faculty of Medicine, University of Tokyo, Japan.

OBJECTIVE The contribution of the polymorphism of complement C4A and C4B alleles to the pathogenesis of systemic sclerosis (SSc) was studied in Japanese patients. METHODS C4A and C4B typing was carried out in 44 SSc patients and in 83 normal subjects using electrophoresis followed by immunofixation and immunoblotting. HLA-DR typing and HLA DRB1*15 and *08 genotyping were carried out by the PCR method and the PCR-SSCP method, respectively. RESULTS In SSc with diffuse scleroderma, the frequency of C4BQ0 was significantly increased (44.4%, p < 0.001, pc < 0.01). In SSc with antitopoisomerase I antibody (a-Scl-70) C4BQ0 was also increased (50.0%, p < 0.001, pc < 0.01). Association analysis indicated that the increase in C4BQ0 was not primary but reflected an increase in HLA-DRB1*1502. In contrast, C4A/Q0 was significantly increased in limited scleroderma (53.8%, p < 0.005, pc < 0.05) and SSc without a-SCL-70 (53.8%, p < 0.005, pc < 0.05). CONCLUSIONS Diffuse scleroderma with SSC with a-Scl-70 have different genetical backgrounds from limited scleroderma and SSc without a-Scl-70, respectively, in Japanese patients. C4AQ0 were independent genetic markers for each clinical subgroup and for a a-Scl-70 positivity.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D005260 Female Females
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Takeuchi, and H Nabeta, and G H Hong, and K Matsuta, and K Tokunaga, and K Tanimoto, and K Nakano
April 1992, Clinical and experimental immunology,
F Takeuchi, and H Nabeta, and G H Hong, and K Matsuta, and K Tokunaga, and K Tanimoto, and K Nakano
January 1989, Immunogenetics,
F Takeuchi, and H Nabeta, and G H Hong, and K Matsuta, and K Tokunaga, and K Tanimoto, and K Nakano
February 1983, British medical journal (Clinical research ed.),
F Takeuchi, and H Nabeta, and G H Hong, and K Matsuta, and K Tokunaga, and K Tanimoto, and K Nakano
October 1986, Arthritis and rheumatism,
F Takeuchi, and H Nabeta, and G H Hong, and K Matsuta, and K Tokunaga, and K Tanimoto, and K Nakano
August 1988, Arthritis and rheumatism,
F Takeuchi, and H Nabeta, and G H Hong, and K Matsuta, and K Tokunaga, and K Tanimoto, and K Nakano
January 2008, BMC medical genetics,
F Takeuchi, and H Nabeta, and G H Hong, and K Matsuta, and K Tokunaga, and K Tanimoto, and K Nakano
January 1990, The Journal of experimental medicine,
F Takeuchi, and H Nabeta, and G H Hong, and K Matsuta, and K Tokunaga, and K Tanimoto, and K Nakano
March 1993, The Journal of rheumatology,
F Takeuchi, and H Nabeta, and G H Hong, and K Matsuta, and K Tokunaga, and K Tanimoto, and K Nakano
August 2002, Journal of immunology (Baltimore, Md. : 1950),
F Takeuchi, and H Nabeta, and G H Hong, and K Matsuta, and K Tokunaga, and K Tanimoto, and K Nakano
October 1992, The Journal of clinical investigation,
Copied contents to your clipboard!